CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
Authors:
- 25 November 2022
- journal article
- research article
- Published by Elsevier in Ageing Research Reviews
- Vol. 83, 101809
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81871607, 82070422)
- Key Research and Development Projects of Shaanxi Province (2020ZDLSF04-03)
This publication has 110 references indexed in Scilit:
- Inhibition of the CXCL12/CXCR4-Axis as Preventive Therapy for Radiation-Induced Pulmonary FibrosisPLOS ONE, 2013
- X4 Human Immunodeficiency Virus Type 1 gp120 Promotes Human Hepatic Stellate Cell Activation and Collagen I Expression through Interactions with CXCR4PLOS ONE, 2012
- The Role of Fibrocytes in Sickle Cell Lung DiseasePLOS ONE, 2012
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemiaBlood, 2012
- Scraping fibrosis: Expressway to the core of fibrosisNature Medicine, 2011
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide AntagonistsScience, 2010
- Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer PrognosisClinical Cancer Research, 2009
- Hepatic stellate cells express functional CXCR4Hepatology, 2009
- CXCR4 in Cancer and Its Regulation by PPARγPPAR Research, 2008
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998